Who We Are:

ReCode Therapeutics is a clinical-stage genetic medicines company using precision delivery to power the next wave of mRNA and gene correction therapeutics. ReCode’s proprietary Selective Organ Targeting (SORT) lipid nanoparticle (LNP) platform enables highly precise and targeted delivery of genetic medicines directly to the organs, tissues and cells implicated in disease, enabling improved efficacy and potency. ReCode’s lead programs include RCT1100 for the treatment of primary ciliary dyskinesia caused by pathogenic mutations in the DNAI1 gene, and RCT2100 for the treatment of the 10-13% of cystic fibrosis patients who have Class I mutations in the CFTR gene and do not respond to currently approved CFTR modulators. RCT1100 and RCT2100 are inhaled disease-modifying mRNA-based therapies formulated using the SORT LNP delivery platform. ReCode is expanding its pipeline to develop potential therapies for other rare and common genetic diseases, including musculoskeletal, central nervous system, liver and infectious disease indications.

Position Summary:

We are seeking an experienced and dynamic leader to join ReCode Therapeutics as the Head of Translational Sciences & Nonclinical Operations. In this role, you will report into our SVP of Early Development and will play a pivotal role in driving the nonclinical and translational sciences strategy, ensuring alignment with clinical development plans, and navigating regulatory pathways to support clinical development and marketing approvals.

Responsibilities:

Oversee and provide strategic direction for Toxicology/Pathology, BioAnalytical/DMPK, Biomarkers, and Clinical Pharmacology teams to ensure robust support for clinical development programs.
Assume responsibility for delivering high-quality data packages to regulatory authorities, supporting marketing approvals.
Collaborate closely with cross-functional teams to align nonclinical and translational sciences deliverables with clinical development plans.
Develop contingency plans and backup scenarios to proactively mitigate unforeseen circumstances and minimize potential impact on timelines.
Develop and implement strategic plans for nonclinical operations, anticipating challenges and ensuring the organization is well-prepared to address them.
Maintain a proactive approach to adapt functional strategies to the evolving scientific and regulatory landscapes, monitoring the regulatory and competitive landscape to design base case and best case scenarios for regular and expedited global approval pathways.
Identify, retain, and manage consultants and external subject matter experts (SMEs) as needed to enhance and adjust functional strategies based on the latest scientific insights and regulatory requirements.
Foster collaborations with key opinion leaders and external partners to stay at the forefront of developments in translational sciences.
Support and coach subject matter experts in the authoring and preparation of CTD/CTA modules, providing guidance in responding to health authority queries and contributing to the preparation of briefing documents for health authority interactions as needed
Act as program lead for translational deliverables on selected key programs and/or oversee and mentor program/project translational lead(s) in a matrix environment
Opportunity to take on full (end-to-end) project team leadership responsibilities for dedicated program(s) based on bandwidth and interest

Qualifications:

Advanced degree in life sciences or medicine (PhD/MD/PharmD preferred)
12+ years of experience in the biopharma industry in non-clinical development (toxicology, pharmacology, pharmacokinetics, bioanalytical sciences, or related discipline)
Strong understanding of science and drug development, with specific expertise in nonclinical study design, preclinical CROs, data management systems, nonclinical study procedures, and statistical analysis methods
Comprehensive knowledge of GLP regulations, including previous GLP experience in pharmaceutical or biotechnology industry or equivalent GXP transferable experience
Background in rare diseases, genetic medicines, gene therapy and/or lipid nanoparticles a plus
Strong knowledge of global regulatory requirements, including FDA (CBER), EMA, MHRA, and other major regulatory authorities with prior experience supporting regulatory submissions.
Excellent communication and interpersonal skills with the ability to collaborate and work effectively in a cross-functional, fast-paced environment.
Strong leadership skills, high scientific integrity, and ability to positively influence cross-functional efforts to drive optimal outcomes for programs.

Salary Range: 265-300K

*Please note that for remote positions, salary may be adjusted for cost of living

Benefits Offered for Full-Time Employees:

No premium cost for employees - 100% subsidized by ReCode for full-time employees
Company 401k contribution
15 days of company paid holidays, including a holiday shutdown (usually the last week of the year)
Mental health support for employees & their families
FSA available, including a lifestyle spending account subsidized by company
Employee discounts at hotspots

ReCode Therapeutics (www.recodetx.com) offers a competitive compensation/benefits package with a friendly, collaborative culture that values employee engagement and ongoing career development.

ReCode Therapeutics is an Equal Opportunity Employer.

Compensation Overview

6 month growth

1 year growth

2 year growth